Surveillance Study of the Contraceptive Intrauterine Device UT380®
NCT03642171 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-03-21
Summary
The study is a long term Post Market Surveillance Study involving women who will received UT 380® device as a contraceptive method.
Conditions
- Contraceptive; Complications, Intrauterine
Sponsors & Collaborators
-
Prodimed S.A.
collaborator OTHER -
CCD
collaborator UNKNOWN -
Quanta Medical
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-07-26
- Primary Completion
- 2023-07-26
- Completion
- 2024-09-23
Countries
- France
Study Locations
More Related Trials
-
Patient Compliance With Long-Acting Reversible Contraception Administration
NCT03305081 ·Status: TERMINATED ·Phase: NA
-
Ovarian Function With ENG Implant and UPA Use
NCT04291001 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
European Active Surveillance Study for Intrauterine Devices
NCT00461175 ·Status: COMPLETED
-
Improvement of Symptoms After Removal of the Essure® Contraceptive Implant
NCT06355713 ·Status: RECRUITING ·Phase: NA
-
Home-based Delivery of the Contraceptive Implant in Postpartum Guatemalan Women
NCT04005391 ·Status: COMPLETED ·Phase: NA
-
Quick Start of Highly Effective Contraception
NCT02076217 ·Status: COMPLETED
-
Acceptability of Depo-subQ in Uniject
NCT01667276 ·Status: COMPLETED
-
Safety of the Etonogestrel-releasing Implant During the Puerperium of Healthy Women
NCT00828542 ·Status: COMPLETED ·Phase: NA
-
Impact of ESSURE Devices Withdrawal on the Symptomatology of Patients
NCT03623126 ·Status: COMPLETED
-
Comparison of Pain Level During Intrauterine Device (IUD) Insertion Between Conventional and Direct Method
NCT03473717 ·Status: UNKNOWN ·Phase: NA
-
A Study on the Safety and Efficacy of the SCu300A IUB Compared to the TCu380 Copper IUD
NCT02036203 ·Status: WITHDRAWN ·Phase: NA
-
Long-Acting Reversible Contraception
NCT01299116 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles
NCT05139121 ·Status: COMPLETED ·Phase: PHASE3
-
Early Versus Standard Postpartum Insertion of the Etonogestrel Contraceptive Implant
NCT00847587 ·Status: COMPLETED ·Phase: PHASE4
-
DIU-QoL. Quality of Life Evaluation in Intrauterine Device Users.
NCT01731132 ·Status: COMPLETED
-
Etonogestrel Implant as Emergency Contraception
NCT05237141 ·Status: RECRUITING ·Phase: PHASE4
-
The Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
NCT01861886 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Safety of a New Inserter Device for Paragard® (Intrauterine Copper Contraceptive)
NCT05309694 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Contraceptive Pills Versus Levonorgestrel-Releasing Intrauterine System for Niche-Related Abnormal Uterine Bleeding
NCT07229209 ·Status: COMPLETED ·Phase: NA
-
Immediate Postpartum Insertion of Contraceptive Intrauterine Devices
NCT03657602 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Combined Hormonal Contraceptive Use in High Risk Women: A Longitudinal Study
NCT00361400 ·Status: COMPLETED
-
Postpartum Etonogestrel Implant for Adolescents
NCT01666912 ·Status: COMPLETED ·Phase: PHASE4
-
Intervention to End Recurrent Unscheduled Bleeding Trial
NCT03118297 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Copper IUD or Oral Levonorgestrel and the Levonorgestrel IUD for Women Seeking Emergency Contraception
NCT01963962 ·Status: COMPLETED
-
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
NCT00995150 ·Status: TERMINATED ·Phase: PHASE3